|
Spdr Ser Tr S&p Biotech Put Option
(XBI)
|
9.1 |
$68M |
|
750k |
90.06 |
|
Xenon Pharmaceuticals
(XENE)
|
6.1 |
$46M |
|
1.2M |
39.20 |
|
Apogee Therapeutics
(APGE)
|
5.7 |
$42M |
|
932k |
45.30 |
|
Arcellx Common Stock
(ACLX)
|
4.4 |
$33M |
|
425k |
76.69 |
|
Alkermes SHS
(ALKS)
|
4.2 |
$32M |
|
1.1M |
28.76 |
|
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
4.1 |
$31M |
|
1.4M |
22.04 |
|
Verona Pharma Sponsored Ads
(VRNA)
|
4.1 |
$31M |
|
660k |
46.44 |
|
Madrigal Pharmaceuticals
(MDGL)
|
3.4 |
$26M |
|
83k |
308.57 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
3.2 |
$24M |
|
460k |
51.13 |
|
Nuvalent Inc-a
(NUVL)
|
3.0 |
$22M |
|
285k |
78.28 |
|
Spyre Therapeutics Com New
(SYRE)
|
2.6 |
$19M |
|
824k |
23.28 |
|
Wave Life Sciences SHS
(WVE)
|
2.5 |
$19M |
|
1.5M |
12.37 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
2.5 |
$18M |
|
1.1M |
16.75 |
|
Vera Therapeutics Cl A
(VERA)
|
2.4 |
$18M |
|
425k |
42.29 |
|
Nurix Therapeutics
(NRIX)
|
2.4 |
$18M |
|
940k |
18.84 |
|
Mesoblast Spons Adr Put Option
(MESO)
|
2.2 |
$17M |
|
839k |
19.80 |
|
Merus N V
(MRUS)
|
2.2 |
$16M |
|
389k |
42.05 |
|
Coherus Biosciences Note 1.500% 4/1 (Principal)
|
2.2 |
$16M |
|
17M |
0.97 |
|
Omeros Corp Note 5.250% 2/1 (Principal)
|
2.0 |
$15M |
|
16M |
0.94 |
|
Establishment Labs Holdings Ord
(ESTA)
|
1.7 |
$13M |
|
279k |
46.07 |
|
Arvinas Ord
(ARVN)
|
1.6 |
$12M |
|
630k |
19.17 |
|
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
1.6 |
$12M |
|
15M |
0.78 |
|
Inozyme Pharma
(INZY)
|
1.5 |
$11M |
|
4.0M |
2.77 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
1.5 |
$11M |
|
425k |
25.70 |
|
Autolus Therapeutics Spon Ads
(AUTL)
|
1.4 |
$11M |
|
4.5M |
2.35 |
|
Geron Corporation
(GERN)
|
1.1 |
$8.0M |
|
2.3M |
3.54 |
|
Amgen Call Option
(AMGN)
|
1.0 |
$7.8M |
|
30k |
260.64 |
|
Rezolute Com New
(RZLT)
|
1.0 |
$7.7M |
|
1.6M |
4.90 |
|
Proqr Thrapeutics N V Shs Euro
(PRQR)
|
1.0 |
$7.5M |
|
2.8M |
2.65 |
|
Oruka Therapeutics
(ORKA)
|
1.0 |
$7.1M |
|
369k |
19.39 |
|
Axsome Therapeutics
(AXSM)
|
0.9 |
$6.3M |
|
75k |
84.61 |
|
Erasca
(ERAS)
|
0.8 |
$6.3M |
|
2.5M |
2.51 |
|
Soleno Therapeutics
(SLNO)
|
0.8 |
$5.9M |
|
130k |
44.95 |
|
Travere Therapeutics Note 2.250% 3/0 (Principal)
|
0.8 |
$5.7M |
|
6.0M |
0.96 |
|
Arrowhead Pharmaceuticals
(ARWR)
|
0.8 |
$5.6M |
|
300k |
18.80 |
|
Bridgebio Pharma
(BBIO)
|
0.7 |
$5.5M |
|
200k |
27.44 |
|
Neumora Therapeutics Call Option
(NMRA)
|
0.7 |
$5.0M |
|
475k |
10.60 |
|
Protagonist Therapeutics
(PTGX)
|
0.7 |
$5.0M |
|
130k |
38.60 |
|
Mineralys Therapeutics
(MLYS)
|
0.6 |
$4.3M |
|
350k |
12.31 |
|
Perspective Therapeutics Com New
(CATX)
|
0.6 |
$4.1M |
|
1.3M |
3.19 |
|
Cassava Sciences Put Option
(SAVA)
|
0.6 |
$4.1M |
|
1.7M |
2.36 |
|
Avalo Therapeutics Com New
(AVTX)
|
0.5 |
$4.1M |
|
551k |
7.43 |
|
Perceptive Cap Solutions Cor Cl A Ord Shs
(PCSC)
|
0.5 |
$3.6M |
|
350k |
10.18 |
|
Travere Therapeutics
(TVTX)
|
0.5 |
$3.5M |
|
200k |
17.42 |
|
Insmed Com Par $.01
(INSM)
|
0.5 |
$3.5M |
|
50k |
69.04 |
|
Newamsterdam Pharma Company *w Exp 99/99/999
(NAMSW)
|
0.4 |
$3.3M |
|
238k |
14.00 |
|
Compass Pathways Sponsored Ads
(CMPS)
|
0.4 |
$3.2M |
|
851k |
3.78 |
|
Galectin Therapeutics Com New Put Option
(GALT)
|
0.4 |
$3.2M |
|
2.5M |
1.29 |
|
Cullinan Oncology
(CGEM)
|
0.4 |
$3.2M |
|
264k |
12.18 |
|
Miragen Therapeutics
(VRDN)
|
0.4 |
$3.1M |
|
160k |
19.17 |
|
Mirum Pharmaceuticals
(MIRM)
|
0.4 |
$2.9M |
|
71k |
41.35 |
|
Cg Oncology
(CGON)
|
0.4 |
$2.9M |
|
100k |
28.68 |
|
Tectonic Therapeutic
(TECX)
|
0.4 |
$2.7M |
|
58k |
46.17 |
|
Helix Acquisition Corp Ii Cl A Ord Shs
(HLXB)
|
0.4 |
$2.6M |
|
250k |
10.50 |
|
Oaktree Acquisition Corp Iii Unit 10/04/2029
(OACCU)
|
0.3 |
$2.5M |
|
250k |
10.15 |
|
Immunovant
(IMVT)
|
0.3 |
$2.5M |
|
100k |
24.77 |
|
Aerovate Therapeutics
(AVTE)
|
0.3 |
$2.1M |
|
800k |
2.65 |
|
Vaxcyte
(PCVX)
|
0.3 |
$2.0M |
|
25k |
81.86 |
|
Nkarta
(NKTX)
|
0.3 |
$2.0M |
|
800k |
2.49 |
|
Nextcure
(NXTC)
|
0.2 |
$1.8M |
|
2.3M |
0.77 |
|
Anteris Technologies Global
(AVR)
|
0.2 |
$1.7M |
|
300k |
5.58 |
|
Kymera Therapeutics
(KYMR)
|
0.2 |
$1.6M |
|
40k |
40.23 |
|
Apellis Pharmaceuticals
(APLS)
|
0.2 |
$1.6M |
|
50k |
31.91 |
|
Rapt Therapeutics
|
0.2 |
$1.6M |
|
1.0M |
1.58 |
|
Inari Medical Ord
|
0.2 |
$1.3M |
|
25k |
51.05 |
|
Savara
(SVRA)
|
0.2 |
$1.3M |
|
411k |
3.07 |
|
Onkure Therapeutics Com Cl A
(OKUR)
|
0.2 |
$1.2M |
|
144k |
8.60 |
|
Black Diamond Therapeutics
(BDTX)
|
0.2 |
$1.2M |
|
559k |
2.14 |
|
Context Therapeutics
(CNTX)
|
0.1 |
$1.1M |
|
1.0M |
1.05 |
|
Kezar Life Sciences Com New
(KZR)
|
0.1 |
$956k |
|
142k |
6.72 |
|
Eliem Therapeutics
(CLYM)
|
0.1 |
$900k |
|
500k |
1.80 |
|
Radiopharm Theranostics Sponsored Ads
(RADX)
|
0.1 |
$684k |
|
156k |
4.38 |
|
Immunitybio Put Option
(IBRX)
|
0.1 |
$640k |
|
250k |
2.56 |
|
Biomea Fusion Put Option
(BMEA)
|
0.1 |
$582k |
|
150k |
3.88 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.1 |
$558k |
|
223k |
2.50 |
|
Syros Pharmaceuticals Com New
(SYRS)
|
0.1 |
$389k |
|
1.7M |
0.23 |
|
Celldex Therapeutics Com New
(CLDX)
|
0.0 |
$253k |
|
10k |
25.27 |
|
Adagio Med Hldgs
(ADGM)
|
0.0 |
$224k |
|
213k |
1.05 |
|
Repare Therapeutics Ord
(RPTX)
|
0.0 |
$131k |
|
100k |
1.31 |
|
Omeros Corporation
(OMER)
|
0.0 |
$98k |
|
10k |
9.88 |
|
Q32 Bio
(QTTB)
|
0.0 |
$96k |
|
28k |
3.44 |
|
Immatics *w Exp 07/01/202
(IMTXW)
|
0.0 |
$47k |
|
187k |
0.25 |
|
Rocket Pharmaceuticals *w Exp 09/02/202
(RCKTW)
|
0.0 |
$2.6k |
|
75k |
0.03 |